Markus Laimer

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Markers of chronic inflammation and obesity: a prospective study on the reversibility of this association in middle-aged women undergoing weight loss by surgical intervention

Markus Laimer, Susanne Kaser, A. Sandhofer et al. · International Journal of Obesity · 2002 · 193 citations

Medicine, Endocrinology, Surgery +13

Temporal Trends and Contemporary Use of Insulin Pump Therapy and Glucose Monitoring Among Children, Adolescents, and Adults With Type 1 Diabetes Between 1995 and 2017

Louisa van den Boom, Beate Karges, Marie Auzanneau et al. · Diabetes Care · 2019 · 183 citations

Medicine, Endocrinology, Pediatrics +17

Effect of Mirtazapine Treatment on Body Composition and Metabolism

Markus Laimer, Karin Kramer-Reinstadler, Markus Rauchenzauner et al. · The Journal of Clinical Psychiatry · 2006 · 102 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

Glycaemic control in individuals with type 1 diabetes using an open source artificial pancreas system (OpenAPS)

Andreas Melmer, Thomas Züger, Dana Lewis et al. · Diabetes Obesity and Metabolism · 2019 · 94 citations

Medicine, Endocrinology, Biosensors +16